ENDRA Life Sciences (NDRA) FCF Margin (2016 - 2018)
ENDRA Life Sciences (NDRA) posted quarterly FCF Margin of 39713.15% for Q1 2018, down 97.76% quarter-over-quarter from 20081.52% in Q4 2017.
ENDRA Life Sciences (NDRA) FCF Margin (2016 - 2018) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported FCF Margin for 3 consecutive years, with 39713.15% the latest figure, recorded in Q1 2018.
- In Q1 2018, FCF Margin changed N/A year-over-year to 39713.15%; the TTM figure through Dec 2018 stood at 126376.43% (down 12543767.0% YoY), while the FY2018 annual figure was 126376.43%, down 12543543.0% from the prior year.
- FCF Margin slipped to 39713.15% in Q1 2018 per NDRA's latest filing, from 20081.52% in the prior quarter.
- Across five years, FCF Margin topped out at 105.93% in Q4 2016 and bottomed at 39713.15% in Q1 2018.
- Historically, FCF Margin has averaged 12413.71% across 3 years, with a median of 1977.51% in 2017.
- On a YoY basis, FCF Margin climbed as much as 1997559 bps in 2017 and fell as far as 1997559 bps in 2017.
- ENDRA Life Sciences' FCF Margin stood at 105.93% in 2016, then tumbled by 18857 bps to 20081.52% in 2017, then slumped by 98 bps to 39713.15% in 2018.
- Business Quant data shows NDRA's FCF Margin at 39713.15% in Q1 2018, 20081.52% in Q4 2017, and 190.46% in Q3 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 13.97% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 20.19% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -1.15% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 10.95% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 8.24% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 26.51% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 13.89% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 27.51% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 8.41% |
| 10 | ENDRA Life Sciences | 7.16 Mn | 1.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | -39,713.15% |
| Dec 31, 2017 | -20,081.52% |
| Sep 30, 2017 | -190.46% |
| Jun 30, 2017 | -1,977.51% |
| Dec 31, 2016 | -105.93% |